NEW YORK (GenomeWeb) – Invitae today announced that it is expecting revenues of more than $144 million in 2018, more than double the revenue it generated in 2017.

As part of a preliminary financials report, the company said it doubled testing volume year over year to more than 302,000 samples compared to around 150,000 in 2017. The revenue projections are approximately $2 million above consensus Wall Street estimates, and testing volume exceeds the company's own prior guidance of 285,000 samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.